Skip to main content

Table 2 CMR parameters according to age

From: Age and sex corrected normal reference values of T1, T2 T2* and ECV in healthy subjects at 3T CMR

  Total population n = 75 [20–30] n = 10 [30-40] n = 9 [40-50] n = 9 [50-60] n = 11 [60-70] n = 11 [70-80] n = 20 >or = 80 n = 5 P value
LV EDVi (ml/m2) 79 ± 17 [48;119] 98 ± 11ǂ*ε [87;118] 93 ± 14ε [72;121] 82 ± 12†ε [60;102] 78 ± 13†ε [65;107] 82 ± 15ε [57;102] 66 ± 12†¥ǂ*$ [46;91] 59 ± 7†¥ǂ*$ [50;66] <0.001
LV ESVi (ml/m2) 29 ± 9 [14;50] 40 ± 7*$ε [32;50] 34 ± 8ε [18;45] 32 ± 8ε [21;45] 28 ± 7† [18;42] 29 ± 8† [16;42] 24 ± 6†¥ǂ [15;35] 17 ± 5†¥ǂ*$ [11;25] <0.001
LV-EF (%) 64 ± 6 [55;76] 59 ± 3 [54;63] 64 ± 5 [57;75] 61 ± 5 [55;72] 64 ± 6 [55;75] 66 ± 6 [57;76] 65 ± 4 [55;68] 72 ± 6†ǂ [62;78] 0.03
LV mass i (g/m2) 58 ± 11 [36;81] 56 ± 9 [44;72] 58 ± 9 [49;78] 54 ± 15 [35;68] 56 ± 7 [46;67] 64 ± 12 [44;82] 59 ± 13 [36;79] 60 ± 11 [48;70] 0.56
Mass/Vol ratio (%) 0.8 ± 0.2 [0.5;1.2] 0.6 ± 0.05$ε [0.5;0.7] 0.6 ± 0.1ε [0.5;0.8] 0.7 ± 0.2 ε [0.4;0.9] 0.7 ± 0.1 ε [0.6;0.8] 0.8 ± 0.1† [0.7;1.0] 0.9 ± 0.1†¥ǂ* [0.7;1.2] 1.0 ± 0.3†¥ǂ*$ [0.8;1.4] <0.001
RV-EDVi (ml/m2) 82 ± 18 [52;132] 104 ± 17ǂ*ε [83;132] 95 ± 17ε [71;133] 83 ± 12† [63;105] 78 ± 12† [64;105] 87 ± 18ε [67;129] 69 ± 12†¥$ [51;92] 68 ± 11†¥$ [57;80] <0.001
RV-ESVi (ml/m2) 35 ± 10 [19;63] 47 ± 10ǂ*$ε [35;64] 40 ± 8ε [26;55] 37 ± 4†ε [30;45] 32 ± 8† [24;44] 38 ± 8†ε [25;52] 28 ± 7†¥ǂ$ [16;40] 25 ± 6†¥ǂ$ [19;34] <0.001
RV EF (%) 58 ± 5 [48;68] 55 ± 3*ε [49;59] 58 ± 4 [50;63] 55 ± 2*ε [52;58] 59 ± 5†ǂ [49;67] 57 ± 3 [52;63] 59 ± 6†ǂ [47;75] 63 ± 5†ǂ$ [56;66] 0.007
T1 (ms) Whole myoc 1122 ± 57 [977;1225] 1070 ± 80$ε [885;1149] 1114 ± 43 [1038;1158] 1100 ± 54 [990;1186] 1132 ± 42 [1069;1188] 1144 ± 51† [1089;1239] 1141 ± 42 [1047;1223] 1142 ± 64† [1042;1212] 0.01
septum 1162 ± 81 [954;1285] 1066 ± 133 [768;1209] 1141 ± 76 [987;1233] 1142 ± 78 [991;1225] 1182 ± 40 [1099;1232] 1182 ± 60 [1108;1305] 1196 ± 42 [1094;1266] 1188 ± 75 [1081;1282] 0.01
ECV % Whole myoc 26.6 ± 3.2 [21.6;34.5] 25.1 ± 1.7 [22.7;27.7] 24.8 ± 1.9 [22.2;27.7] 27.3 ± 4.3 [21.6;33.7] 25.0 ± 1.9 [22.9;29.6] 27.1 ± 4.6 [22.2;34.6] 28.0 ± 2.6 [21.6;31.0] 29.1 ± 1.3 [28.1;31.2] 0.01
septum 27.5 ± 3.8 [21.0;37.6] 26.7 ± 1.3 [24.5;28.3] 26.4 ± 4.2 [21.0;35.0] 28.9 ± 6.0 [21.7;40.3] 25.9 ± 1.9 [22.6;29.7] 26.4 ± 4.2 [21.0;34.4] 28.7 ± 3.8 [21.9;36.9] 29.9 ± 1.8 [27.4;32.5] 0.19
T2 (ms) Whole myoc 52 ± 6 [41;61] 53 ± 5 [48;62] 52 ± 4 [46;56] 53 ± 4 [46;58] 55 ± 2 [52;58] 53 ± 7 [43;60] 52 ± 6 [42;63] 43 ± 5 †¥ǂ*$ε [36;48] 0.007
septum 52 ± 7 [38;64] 54 ± 4 [49;59] 53 ± 4 [48;59] 54 ± 4 [47;61] 56 ± 4 [52;63] 53 ± 9 [38;64] 51 ± 6 [41;62] 42 ± 5†¥ǂ*$ε [34;46] 0.004
T2* (ms) Whole myoc 24 ± 5 [12;33] 23 ± 5 [14;30] 26 ± 5 [20;34] 21 ± 6 [13;30] 21 ± 6 [10;29] 24 ± 3 [19;27] 25 ± 5 [13;32] 28 ± 3 [26;32] 0.27
septum 25 ± 5 [11;39] 27 ± 6 [22;39] 26 ± 4 [22;31] 23 ± 8 [11;39] 22 ± 7 [11;31] 24 ± 5 [16;35] 25 ± 4 [19;35] 28 ± 2 [24;31] 0.38
  1. Data are reported as mean ± SD and 95% IQR
  2. p < 0.05 .vs 20-29y; ¥ .vs 30-39y; ǂ .vs 40-49y; * .vs 50-59y; $. Vs 60-69y; ε. vs 70-79y; .vs ≥ 80 & p < 0.05 septum vs whole myocardium of the same group